NCT00347009View on ClinicalTrials.gov

Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis

PHASE4CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Hepatitis B, ChronicCirrhosisFibrosisChronic Hepatitis B
Interventions
DRUG

adefovir dipivoxil

10mg once daily

Trial Locations (12)

100

GSK Investigational Site, Taipei

114

GSK Investigational Site, Taipei

833

GSK Investigational Site, Kaohsiung City

169608

GSK Investigational Site, Singapore

Unknown

GSK Investigational Site, Pokfulam

GSK Investigational Site, Ho Chi Minh City

700-712

GSK Investigational Site, Daegu

602-739

GSK Investigational Site, Pusan

120-752

GSK Investigational Site, Seoul

135-710

GSK Investigational Site, Seoul

137-701

GSK Investigational Site, Seoul

463-712

GSK Investigational Site, Sungnam-City

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00347009 - Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis | Biotech Hunter | Biotech Hunter